Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(25%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_1
1
25%
Ph phase_4
1
25%
Ph early_phase_1
1
25%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated125%
recruiting125%
unknown250%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_4

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

NCT05902078
terminatedphase_1

Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons

NCT04286529
unknownnot_applicable

The Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease Patients

NCT05298163
unknownearly_phase_1

Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu Granules

NCT03563235

Clinical Trials (4)

Showing 4 of 4 trials
NCT05902078Phase 4

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

Recruiting
NCT04286529Phase 1

Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons

Terminated
NCT05298163Not Applicable

The Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease Patients

Unknown
NCT03563235Early Phase 1

Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu Granules

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4